We Need More Indian Women to Make a Mark in Science

By Kiran Mazumdar-Shaw “A ship in port is safe, but that's not what ships are built for,” said Grace Hopper (1906–1992), one of the first programmers in the history of computers. Her belief that programming languages should be as easily understood as English was highly influential on the development of COBOL, one of the first computer … Continue reading We Need More Indian Women to Make a Mark in Science

A Reassuring Budget Focused on Growth, Investment & Jobs

By Kiran Mazumdar-Shaw, Executive Chairperson, Biocon It was very encouraging to see such a pragmatic, growth-focused budget that addresses the key need to boost economic recovery in the aftermath of the COVID-19 impact. This has been reflected in the market cheer following the announcement. The budget covers the major segments which needed redressal with big … Continue reading A Reassuring Budget Focused on Growth, Investment & Jobs

Budget Push can Transform ASHA Workers from Health Activists to Digital Health Agents to deliver on NDHM

By Kiran Mazumdar-Shaw Chairperson, Biocon Group and member of The Lancet Citizen’s Commission on Re-imagining India’s Health System Technology can enable India to leapfrog into an advanced healthcare system that fulfils the vision of the national health policy of promoting wellness, universal access and affordable care for all Indians. The National Digital Health Mission (NDHM) … Continue reading Budget Push can Transform ASHA Workers from Health Activists to Digital Health Agents to deliver on NDHM

Economic Liberalisation and the Changing Face of Healthcare in India

By Kiran Mazumdar-Shaw, Executive Chairperson, Biocon & Biocon Biologics India’s healthcare standards have significantly improved over the past decades. Life expectancy has doubled from 35 years in 1950 to 70 years today. Most infectious diseases have been brought under control. Many key indicators of rural healthcare have also improved: Infant Mortality Rate (IMR) has reduced … Continue reading Economic Liberalisation and the Changing Face of Healthcare in India

Decoding India’s Covid Vaccine Approvals with Kiran Mazumdar-Shaw: Part II

Kiran Mazumdar-Shaw Shaw spoke to Barkha Dutt, editor of Mojo, addressing doubts around India's COVID-19 vaccines rollout, on whether India's two approved vaccines are safe, what the difference is in the approval to the Serum Institute and Bharat Biotech vaccines and who should get the vaccines first. Here's Part 2 of the interview. Barkha: Are … Continue reading Decoding India’s Covid Vaccine Approvals with Kiran Mazumdar-Shaw: Part II

Decoding India’s two approved vaccines and looking at the rollout with Kiran Mazumdar Shaw

Kiran Mazumdar-Shaw Shaw spoke to Barkha Dutt, editor of Mojo, addressing doubts around India's COVID-19 vaccines rollout, on whether India's two approved vaccines are safe, what the difference is in the approval to the Serum Institute and Bharat Biotech vaccines and who should get the vaccines first. Here's Part 1 of the interview. Barkha Dutt: … Continue reading Decoding India’s two approved vaccines and looking at the rollout with Kiran Mazumdar Shaw

Indian regulator has granted Emergency Approval to Covaxin, Covishield based on strong scientific judgment.

India’s health regulator Drugs Controller General of India (DCGI) has granted Emergency Use Authorization (EUA) to two vaccines, Covaxin andCovishield , to fight the COVID-19 pandemic. Covaxin has been developed by Bharat Biotech in collaboration with the Indian Council for Medical Research (ICMR) and National Institute of Virology (NIV). Covishield has been developed by Oxford … Continue reading Indian regulator has granted Emergency Approval to Covaxin, Covishield based on strong scientific judgment.

India needs to inoculate a million people a day against COVID-19

India's health regulator Drugs Controller General of India (DCGI) has granted permission to two vaccines, Covishield and Covaxin, for "restricted use" in an emergency situation to fight the COVID-19 pandemic. Covishield has been developed by Oxford University scientists in collaboration with pharmaceutical company AstraZeneca. In India, its trial was undertaken by the Serum Institute of … Continue reading India needs to inoculate a million people a day against COVID-19

World needs to balance risks, benefits and challenges of deploying COVID-19 vaccines

Biocon Executive Chairperson Kiran Mazumdar-Shaw recently spoke at Carnegie India’s Global Technology Summit, which convened leading policymakers, entrepreneurs, industry leaders, academics and technologists from around the world to deliberate over five days on an overarching theme of ‘Geopolitics of Technology’. On Dec. 18, 2020, the last day of the summit, Ms Mazumdar-Shaw joined Soumya Swaminathan, … Continue reading World needs to balance risks, benefits and challenges of deploying COVID-19 vaccines